{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "12031318", "DateCompleted": {"Year": "2002", "Month": "11", "Day": "12"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "19"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0960-894X", "JournalIssue": {"Volume": "12", "Issue": "11", "PubDate": {"Year": "2002", "Month": "Jun", "Day": "03"}}, "Title": "Bioorganic & medicinal chemistry letters", "ISOAbbreviation": "Bioorg Med Chem Lett"}, "ArticleTitle": "CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitors.", "Pagination": {"StartPage": "1451", "EndPage": "1456", "MedlinePgn": "1451-6"}, "Abstract": {"AbstractText": ["The discovery, synthesis and biological activity of a series of triarylethane phosphodiesterase 4 inhibitors is described. Structure-activity relationship studies are presented for CDP840 (29), a potent, chiral, selective inhibitor of PDE 4 (IC(50) 4nM). CDP840 is non-emetic in the ferret at 30mgkg(-1) (po), active in models of inflammation and reverses ozone-induced bronchial hyperreactivity in the guinea pig."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Celltech R&D Ltd., 208 Bath Road, Slough, Berkshire SL1 3WE, UK. rikki.alexander@celltechgroup.com"}], "Identifier": [], "LastName": "Alexander", "ForeName": "R P", "Initials": "RP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Warrellow", "ForeName": "G J", "Initials": "GJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Eaton", "ForeName": "M A W", "Initials": "MA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Boyd", "ForeName": "E C", "Initials": "EC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Head", "ForeName": "J C", "Initials": "JC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Porter", "ForeName": "J R", "Initials": "JR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Brown", "ForeName": "J A", "Initials": "JA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Reuberson", "ForeName": "J T", "Initials": "JT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hutchinson", "ForeName": "B", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Turner", "ForeName": "P", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Boyce", "ForeName": "B", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Barnes", "ForeName": "D", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mason", "ForeName": "B", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cannell", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Taylor", "ForeName": "R J", "Initials": "RJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zomaya", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Millican", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Leonard", "ForeName": "J", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Morphy", "ForeName": "R", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wales", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Perry", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Allen", "ForeName": "R A", "Initials": "RA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gozzard", "ForeName": "N", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hughes", "ForeName": "B", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Higgs", "ForeName": "G", "Initials": "G"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Bioorg Med Chem Lett", "NlmUniqueID": "9107377", "ISSNLinking": "0960-894X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphodiesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyridines"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "162542-90-7", "NameOfSubstance": "CDP 840"}, {"RegistryNumber": "EC 3.1.4.17", "NameOfSubstance": "3',5'-Cyclic-AMP Phosphodiesterases"}, {"RegistryNumber": "EC 3.1.4.17", "NameOfSubstance": "Cyclic Nucleotide Phosphodiesterases, Type 4"}, {"RegistryNumber": "K676NL63N7", "NameOfSubstance": "Rolipram"}], "MeshHeadingList": [{"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "3',5'-Cyclic-AMP Phosphodiesterases"}, {"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["blood", "chemical synthesis", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Asthma"}, {"QualifierName": ["drug effects"], "DescriptorName": "Bronchoconstriction"}, {"QualifierName": [], "DescriptorName": "Cyclic Nucleotide Phosphodiesterases, Type 4"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Ferrets"}, {"QualifierName": [], "DescriptorName": "Guinea Pigs"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["blood", "chemical synthesis", "pharmacology"], "DescriptorName": "Phosphodiesterase Inhibitors"}, {"QualifierName": ["blood", "chemical synthesis", "pharmacology"], "DescriptorName": "Pyridines"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Rolipram"}, {"QualifierName": ["enzymology"], "DescriptorName": "Saccharomyces cerevisiae"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2002", "Month": "5", "Day": "29", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "11", "Day": "26", "Hour": "4", "Minute": "0"}, {"Year": "2002", "Month": "5", "Day": "29", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12031318", "10.1016/s0960-894x(02)00202-0", "S0960894X02002020"]}}], "PubmedBookArticle": []}